Company

NEXSEN

Biotechnology Research Melbourne, Victoria, Au 8 employees

Employees: 8
Contacts: 4
Emails: 3
Phones: 1

NEXSEN Overview

Headquarters: Melbourne, Victoria, Au
Industry: Biotechnology Research
Employees: 8
Founded: 2021
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Melbourne

About NEXSEN

The Centre for Disease Control (CDC) estimates that 2 to 3 in every 50 babies (4–6%) who develop Group B Streptococcus (GBS) disease will die and on average, about 1 in 20 non-pregnant adults with serious GBS infections dies. Working with some of the top researchers in Australia, NEXSEN BioTech is developing a cutting-edge diagnostic rapid diagnostic tool for Group B Streptococcus to provide effective patient screening. This will provide an immediately available and fully reliable diagnostic result for pregnant women all around the world, and give hope to those who live in countries without access to pathology labs.

NEXSEN Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

NEXSEN Org Chart

Sample employees and titles

Name	Title	Location	Contact
Martina Mariano, Phd, Gaicd	COO @ Singular Health (Asx: Shg) - Ned	Greater Perth Area, Australia	Phone
Mark Muzzin	Managing Director - Nexsen	Melbourne, Victoria, Australia	Email
Pabudi Weerathunge	Research Fellow at Rmit University	Melbourne, Victoria, Australia	Email
Wendy Figueroa	Financial Controller at Nexsen Biotech	Greater Perth Area, Australia	Email